TNFRSF9 and melanoma: Addition of agonistic anti-4-1BB antibody activates 4-1BB signaling in tumor tissues and accelerates the growth of melanoma antigen-specific memory CD8+ T cells by activating NF-κB signaling in CD8+ T cells.